Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
4 studies found for:    sorafenib sclc
Show Display Options
Rank Status Study
1 Unknown  Study of Sorafenib Maintenance in Patients With ED-SCLC After Response to Induction Chemotherapy
Condition: Small Cell Lung Cancer
Intervention: Drug: Sorafenib
2 Suspended Phase I Study of Weekly Topotecan in Combination With Sorafenib in Treatment of Relapsed Small Cell Lung Cancer
Conditions: Small Cell Carcinoma;   Lung Cancer
Interventions: Drug: Topotecan;   Drug: Sorafenib
3 Completed
Has Results
Sorafenib in Treating Patients With Extensive Stage Small Cell Lung Cancer
Conditions: Extensive Stage Small Cell Lung Cancer;   Recurrent Small Cell Lung Cancer
Intervention: Drug: sorafenib tosylate
4 Terminated
Has Results
Sorafenib, Cisplatin, and Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: cisplatin;   Drug: etoposide;   Drug: sorafenib tosylate

Indicates status has not been verified in more than two years